
PharmiWeb Today Story
- Medicines, including insulin, to be available in 40 lower-income countries
- Investment fund established to help create sustainable health systems
- Announcements comes as Global Health stakeholders gather in Paris
Paris – July 4, 2022 – Sanofi Global Health announces the launch of Impact®, a new brand of standard of care medicines produced by Sanofi dedicated for nonprofit distribution to at-risk populations in the world’s most impoverished countries.
The Impact® brand, which includes insulin, glibenclamide and oxaliplatin amonst others, will enable the secure distribution of 30 Sanofi medicines in 40 lower-income countries. Considered essential by the World Health Organization, the medicines cover a wide range of therapeutic areas, including diabetes, cardiovascular disease, tuberculosis, malaria and cancer.
The launch of the Impact® brand is among the steps taken since the formation last year of Sanofi Global Health, a nonprofit unit within the company aiming to increase access to healthcare through the distribution of medicines, and the building and bolstering of local healthcare systems in countries with among the lowest per capita GDP. Sanofi Global Health is the first and only global initiative to provide access to such a broad portfolio of medicines in so many countries and across multiple therapeutic areas while funding local support programs and strengthening local incl…
Read More...
Articles

Focus On: Santen Cell & Gene
10-Jun-2022

12 Ways to Optimise Your Work from Home Space
09-Jun-2022

The Latest Features and News from PharmiWeb.Jobs
07-Jun-2022

Top Pharma and Life Science Events in June 2022
01-Jun-2022

13 Ways to Reduce Employee Burnout
30-May-2022
Featured Events

-
Next Generation Cancer Vaccine Development Summit…
07-Sep-2021 - 09-Sep-2021 -
1st International Conference “WE! are the Clinical…
18-Sep-2021 - 18-Sep-2021 -
Reuters Events: Cell & Gene Therapy USA 2021
28-Sep-2021 - 29-Sep-2021 -
Reuters Events: Pharma 2021
11-Oct-2021 - 22-Oct-2021 -
Pharma USA 2022
16-Mar-2022 - 17-Mar-2022 -
Network Pharma: Working in and Around #MedComms
19-Sep-2022 - 19-Sep-2022
News

-
Summary of ONXEO’s Liquidity Contract with Kepler…
04-Jul-2022 -
Worldwide Passive Electronic Components Industry t…
04-Jul-2022 -
Global Natural Killer Cells Therapeutics Market (2…
04-Jul-2022 -
Sports Nutrition Foods and Drinks Market Report 20…
04-Jul-2022 -
Vietnam Oral Care Market is Projected to Grow at a…
04-Jul-2022 -
CORRECTING and REPLACING Biosynth Carbosynth Expan…
04-Jul-2022